Related Experiment Video
Updated: Oct 23, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Bleeding avoidance strategies in percutaneous coronary intervention
Davide Capodanno1, Deepak L Bhatt2, C Michael Gibson3
1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.
Insights
Minimizing bleeding in percutaneous coronary intervention (PCI) is crucial, as bleeding is a significant negative prognostic factor. New strategies focus on enhancing safety alongside efficacy for antithrombotic treatments and procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Historically, bleeding was accepted as a necessary risk of percutaneous coronary intervention (PCI) to prevent thrombotic events.
- Bleeding is now recognized as a major adverse event, impacting patient prognosis similarly to ischemic complications.
Purpose of the Study:
- To review current data and strategies for minimizing bleeding in patients undergoing PCI.
- To highlight the shift in perspective recognizing bleeding as a critical prognostic factor.
Main Methods:
- Review of contemporary data on bleeding avoidance in PCI.
- Discussion of risk stratification and procedural/pharmacological strategies.
- Analysis of pretreatment, vascular access, stent selection, and antithrombotic regimens.
Main Results:
- Bleeding is a significant negative prognostic indicator in PCI, comparable to thrombotic events.
- A paradigm shift necessitates a focus on safety alongside efficacy in PCI treatments.
- Various strategies can be employed to minimize bleeding risk.
Conclusions:
- Optimizing safety by minimizing bleeding is a key goal in PCI.
- Comprehensive strategies encompassing risk assessment and tailored interventions are essential for effective bleeding avoidance.
- Future PCI approaches must balance antithrombotic efficacy with improved patient safety.
Abstract:
For many years, bleeding has been perceived as an unavoidable consequence of strategies aimed at reducing thrombotic complications in patients undergoing percutaneous coronary intervention (PCI). However, the paradigm has now shifted towards bleeding being recognized as a prognostically unfavourable event to the same extent as having a new or recurrent ischaemic or thrombotic complication. As such, in parallel with progress in device and drug development for PCI, there is clinical interest in developing strategies that maximize not only the efficacy but also the safety (for example, by minimizing bleeding) of any antithrombotic treatment or procedural aspect before, during or after PCI. In this Review, we discuss contemporary data and aspects of bleeding avoidance strategies in PCI, including risk stratification, timing of revascularization, pretreatment with antiplatelet agents, selection of vascular access, choice of coronary stents and antithrombotic treatment regimens.
More Related Videos
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

